Antibody-mediated inhibition of TNFR1 attenuates disease in a mouse model of multiple sclerosis.

Histopathological analysis of spinal cords revealed a reduction in the level of spinal cord demyelination, although, with the applied short treatment protocol, the observed differences did not reach statistical significance at day 14 after disease onset ( Fig. 6C–E ).

also in 111,027 other papers